News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cambridge-Based Gen9 Gets $25 Million In Equity Funding For DNA Synthesis


7/31/2014 7:01:46 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Gen9, a Cambridge-based synthetic biology co-founded in 2009 by Harvard professor George Church, has filed for the receipt of $25 million in equity.

The investment, disclosed in a filing with the Securities and Exchange Commission, more than doubles the amount of equity it has received over the past five years.

Help employers find you! Check out all the jobs and post your resume.



comments powered by Disqus
Gen9
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES